SHP-639

N/A

Report date: 2024/11/07 17:35:56
NME

Base Information

Drug NameSHP-639
Drug Alias NameSHP-639TAK-639
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNatriuretic peptide receptor 3 agonists
TargetsNatriuretic peptide receptor 3
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesShire Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire
Active IndicationsN/A
Inactive IndicationsGlaucoma, Open-AngleOcular Hypertension

Other Information

ATC CodeN/A
Related LinksN/A